High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical S

CHARLOTTE, N.C., Sept. 11 /CNW/ -- In a new study, men with locally
recurrent prostate cancer may be able to receive a promising investigational
ultrasound treatment option.

A Phase III clinical trial at Specialists in Urology, located in North
Naples, FL, is investigating the safety and efficacy of High Intensity Focused
Ultrasound (HIFU) for the treatment of locally recurrent prostate
cancer following failed external beam radiation therapy (EBRT).
HIFU is a minimally invasive procedure that uses ultrasound energy to destroy cancerous tissue with focused sound waves.

The lead investigator of this trial site is Dr. Nicholas Franco. This is
one of several trial sites in the nation approved by the Food and Drug
Administration to participate in the trial, which will begin enrolling
patients in September.

source: CNW Group